Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of Tavapadon, an Orally Administered, Once-daily, Selective D1/D5 Partial Dopamine Agonist, Adjunctive to Levodopa for Treatment of Parkinson’s Disease with Motor Fluctuations

              Author:Fernandez, Hubert   Isaacson, Stuart   Hauser, Robert   Agarwal, Pinky   Ondo, William   Park, Ariane   Elmer, Lawrence   Kremens, Daniel   Leoni, Matthew   Duvvuri, Sridhar   Combs, Cari   Koenig, Erica   Chang, Ih   Pastino, Gina   Tringali, Stacey   Golonski, Nicole   Sanchez, Raymon   

              Session Name:S37: Movement Disorders: Clinical Trials  

              Topic:Movement Disorders  

              Program Number:S37.003  

              Author Institution:Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH  Parkinson's Disease & Movement Disorders Center of Boca Raton, Boca Raton, FL  USF Parkinson's Disease and Movement Disorders Center, Tampa, FL  Evergreen Health, Kirkland, WA  Houston Methodist Neurological Institute, Houston, TX  The Ohio State University Wexner Medical Center, Columbus, OH  Division of Movement Disorders, Department of Neurology, University of Toledo, Toledo, OH  Thomas Jefferson University, Philadelphia, PA  Cerevel Therapeutics, Cambridge, MA